3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Salvage Therapy with Methyl-gag, High-Dose Ara-C, M-Amsa, and Ifosfamide (MAMI) for Recurrent or Refractory Lymphoma

, , , , , , , & show all
Pages 1-5 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rashida Haq, Carol A. Sawka, Edmée Franssen & Neil L. Berinstein. (1999) Mitoxantrone-DHAP with GM-CSF: An Active but Myelosuppressive Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma. Leukemia & Lymphoma 35:5-6, pages 527-536.
Read now

Articles from other publishers (3)

JM Vantelon, S Koscielny, P Brault, JH Bourhis, V Ribrag, J Pico, P Fenaux & JN Munck. (2000) Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice. Bone Marrow Transplantation 25:5, pages 495-499.
Crossref
Yves Pommier. 1997. Cancer Therapeutics. Cancer Therapeutics 153 174 .
W. P. Brade, K. Herdrich, U. Kachel-Fischer & C. E. Araujo. (1991) Dosing and side-effects of ifosfamide plus mesna. Journal of Cancer Research and Clinical Oncology 117:S4, pages S164-S186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.